重症社区获得性肺炎合并2型糖尿病患者的临床特征及死亡相关危险因素
本研究为回顾性观察研究,纳入2011年9月至2019年9月四川大学华西医院ICU收治的成人重症社区获得性肺炎(SCAP)连续病例,以1:2倾向性评分匹配比较合并与不合并2型糖尿病(T2DM)患者的临床特征与结局,主要终点为住院死亡率。匹配后共1262例T2DM患者与2524例非T2DM患者,T2DM组ICU住院时间更长(13天 vs 12天,P=0.016),14天死亡率(15% vs 10.8%,P<0.001)、30天死亡率(25.7% vs 22.7%,P=0.046)、ICU死亡率(30.8% vs 26.5%,P=0.005)和住院死亡率(35.2% vs 31.0%,P=0.009)均更高。在T2DM的SCAP患者中,合并症数量增多和糖尿病相关并发症、CRP、NLR、BNP、血乳酸升高及入院血压降低是住院死亡的独立危险因素。所建列线图在训练集C指数0.907(95%CI 0.888, 0.927)、测试集0.873(95%CI 0.836, 0.911),优于肺炎严重指数(PSI,AUC 0.809,95%CI 0.785, 0.833),校准曲线与决策曲线分析也显示其准确性和适用性。
要点
- SCAP合并T2DM患者住院死亡率35.2% vs 非T2DM 31.0%(P=0.009),ICU死亡率30.8% vs 26.5%(P=0.005),14天死亡率15% vs 10.8%(P<0.001)。
- T2DM组ICU住院时间13天 vs 非T2DM组12天(P=0.016),30天死亡率25.7% vs 22.7%(P=0.046)。
- T2DM的SCAP患者住院死亡独立危险因素包括合并症数量增多、糖尿病相关并发症、CRP、NLR、BNP、血乳酸升高及入院血压降低。
- 列线图预测住院死亡训练集C指数0.907(95%CI 0.888, 0.927)、测试集0.873(95%CI 0.836, 0.911),优于PSI的AUC 0.809(95%CI 0.785, 0.833)。
- 作者认为该列线图对住院死亡有良好预测性能,可能在更多外部验证后普遍应用。
适用人群与场景
- 2011年9月至2019年9月四川大学华西医院ICU收治的连续成人重症社区获得性肺炎(SCAP)患者。
- 匹配后分析人群为1262例合并2型糖尿病(T2DM)的SCAP患者与2524例不合并T2DM的匹配患者。
研究设计与关键结果
- 研究类型为回顾性观察研究,单中心(四川大学华西医院ICU),纳入成人SCAP连续病例,采用1:2倾向性评分匹配比较T2DM与非T2DM患者,主要终点为住院死亡率。
- 匹配后T2DM组1262例 vs 非T2DM组2524例:ICU住院时间13天 vs 12天(P=0.016),14天死亡率15% vs 10.8%(P<0.001),30天死亡率25.7% vs 22.7%(P=0.046),ICU死亡率30.8% vs 26.5%(P=0.005),住院死亡率35.2% vs 31.0%(P=0.009)。
- 在合并T2DM的SCAP患者中,住院死亡的独立危险因素为:合并症数量增多、糖尿病相关并发症、CRP升高、NLR升高、BNP升高、血乳酸升高及入院血压降低。
- 列线图预测住院死亡的C指数:训练集0.907(95%CI 0.888, 0.927),测试集0.873(95%CI 0.836, 0.911);优于PSI的AUC 0.809(95%CI 0.785, 0.833)。
- 校准曲线和决策曲线分析(DCA)显示列线图具有准确性和适用性。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:作者结论指出该列线图需在更多外部验证后才可能普遍应用。
对床旁实践的改变
- 对ICU收治的SCAP合并T2DM患者,可关注合并症数量、糖尿病相关并发症、CRP、NLR、BNP、血乳酸升高及入院血压降低等住院死亡独立危险因素。
- 作者认为该列线图对住院死亡有良好预测性能,可能在更多外部验证后普遍应用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The present study was performed to investigate the impacts of type 2 diabetes mellitus (T2DM) on severe community-acquired pneumonia (SCAP) and to develop a novel prediction model for mortality in SCAP patients with T2DM.
METHODS: This was a retrospective observational study conducted in consecutive adult patients with SCAP admitted to the intensive care unit (ICU) of West China Hospital, Sichuan University, China, between September 2011 and September 2019. The primary outcome was hospital mortality. A propensity score matching (PSM) analysis model with a 1:2 ratio was used for the comparisons of clinical characteristics and outcomes between T2DM and nondiabetic patients. The independent risk factors were identified via univariate and then multivariable logistic regression analysis and were then used to establish a nomogram.
RESULTS: In total, 1262 SCAP patients with T2DM and 2524 matched patients without T2DM were included after PSM. Patients with T2DM had longer ICU length of stay (LOS) (13 vs. 12 days, P = 0.016) and higher 14-day mortality (15% vs. 10.8%, P < 0.001), 30-day mortality (25.7% vs. 22.7%, P = 0.046), ICU mortality (30.8% vs. 26.5%, P = 0.005), and hospital mortality (35.2% vs. 31.0%, P = 0.009) than those without T2DM. In SCAP patients with T2DM, the independent risk factors for hospital mortality were increased numbers of comorbidities and diabetes-related complications; elevated C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), brain natriuretic peptide (BNP) and blood lactate; as well as decreased blood pressure on admission. The nomogram had a C index of 0.907 (95% CI: 0.888, 0.927) in the training set and 0.873 (95% CI: 0.836, 0.911) in the testing set, which was superior to the pneumonia severity index (PSI, AUC: 0.809, 95% CI: 0.785, 0.833). The calibration curve and decision curve analysis (DCA) also demonstrated its accuracy and applicability.
CONCLUSIONS: SCAP patients with T2DM had worse clinical outcomes than nondiabetic patients. The nomogram has good predictive performance for hospital mortality and might be generally applied after more external validations.
参考来源
- Huang D, He D, Gong L, et al. Clinical characteristics and risk factors associated with mortality in patients with severe community-acquired pneumonia and type 2 diabetes mellitus. Crit Care. 2021. PMID: 34876193. doi:10.1186/s13054-021-03841-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。